TAG ARCHIVE

POSTS TAGGED AS Pfizer

World’s Largest Browsable Resource Linking Rare Protein-Coding Genetic Variants to Human Health and Disease

October 12, 2021 | | Posted in Newsletter

Genebass resource linking protein-coding variants to health and disease
“Genebass [sic] is a resource of exome-based association statistics, made available to [MORE]

Scripps Florida Acquires Pfizer’s Microbial Sample Library

March 3, 2020 | | Posted in Newsletter

Ben Shen microbial collection assembled by Pfizer
For nearly a century, the pharmaceutical company collected microorganisms of potential drug value.  Now [MORE]

Biorepository Collaboration

September 21, 2010 | | Posted in Newsletter

Liver Cancer Care
Earlier this year, Pfizer, Eli Lilly, and Merck agreed to create a nonprofit Asian Cancer Research Group [MORE]

Social Networking for Clinical Trials

September 29, 2009 | | Posted in Newsletter

Drug-maker Pfizer (New York City) has engaged the social networking company, Private Access (Irvine, CA) to create what the partners [MORE]

SNP Doctor

March 10, 2009 | | Posted in Newsletter

Researchers at the Imperial College, London and their commercial spin-out, DNA Electronics, have devised a handheld instrument that does a [MORE]

Non-invasive Glucose Monitoring

January 20, 2009 | | Posted in Newsletter

Solianis Monitoring AG (Zurich, Switzerland) has recently completed a study of its wearable, noninvasive, multisensor glucose monitor that tracks blood [MORE]

Pfizer’s Business Refocus

October 14, 2008 | | Posted in Newsletter

Pfizer believes that its highest payoff for R&D will be in oncology, pain, inflammation, diabetes, Alzheimer’s’ disease and [MORE]